Navigation Links
Unraveling Batten disease
Date:11/2/2011

Waste management is a big issue anywhere, but at the cellular level it can be a matter of life and death. A Weizmann Institute study, published in the Journal of Cell Biology, has revealed what causes a molecular waste container in the cell to overflow in Batten disease, a rare but fatal neurodegenerative disorder that begins in childhood. The findings may form the basis for a therapy for this disorder.

In Batten disease, an insoluble yellow pigment accumulates in the brain's neurons, causing these cells to degenerate and ultimately die. Patients gradually become disabled, losing their vision and motor skills and suffering mental impairment; they rarely survive beyond their early twenties. It's been known for a while that the disorder is caused by a mutation in the gene referred to as CLN3, but the role of this gene in the cell was unknown. This role has now been discovered in the Weizmann Institute study, explaining the molecular dysfunction in Batten disease.

The research was conducted in the laboratory of Prof. Jeffrey Gerst of the Molecular Genetics Department by Rachel Kama and postdoctoral fellow Dr. Vydehi Kanneganti, in collaboration with Prof. Christian Ungermann of the University of Osnabrueck in Germany. All the studies were performed in yeast: The yeast equivalent of the mammalian CLN3 gene has been conserved almost intact in the course of evolution, making them ideal models for study. In fact, so similar are the yeast and the mammalian genes that when the researchers replaced a missing copy of the yeast gene with a working copy of mammalian CLN3, normal functioning of the yeast cell was restored.

The experiments showed that the yeast equivalent of CLN3 is involved in moving proteins about the cell the scientific term is "protein trafficking." The gene activates an enzyme of the kinase family, which, in turn, launches a series of molecular events regulating the trafficking. When the yeast CLN3 is mutated, this trafficking is disrupted. As a result, certain proteins accumulate abnormally in the lysosome, the cell's waste-recycling machine, instead of being transported to another destination. At some point the lysosome is filled beyond capacity; it then interferes with molecular signaling and other vital processes in the neuron, eventually killing the cell.

A great deal of research must still be performed before this finding benefits humans, but the clarification of the CLN3 function is precisely what might help develop a new therapy. Replacing the defective CLN3 in all the brain's neurons is a daunting challenge, but replacing its function for example, by activating the relevant kinase by means of a drug should be much more feasible.


'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Related biology news :

1. Unraveling a new regulator of cystic fibrosis
2. Unraveling Alzheimers: Simple small molecules could untangle complex disease
3. Tel Aviv University President Co-authors Important Paper Unraveling the Effect of Spatial Organization on Intracellular Chemistry
4. New book offers practical advice for unraveling the genetics of complex human diseases
5. March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
6. Physics, math provide clues to unraveling cancer
7. Brain structure provides key to unraveling function of bizarre dinosaur crests
8. OHSU Doernbecher Childrens Hospital conducts second phase of landmark Batten study
9. Mutation in gene associated with rare eye disease also contributes to bladder cancer growth
10. Scientists discover new drug candidates for cystic fibrosis and other diseases
11. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/15/2016)... Germany , December 15, 2016 ... announced an agreement with NuData Security, an award-winning ... partnership will enable clients to focus on good customer experience, ... protection regulation. ... In order to provide a one-stop fraud prevention suite, ...
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... Reha Technology USA Inc. has ... . The need for Robotic technology in the rehab space ... in the surgical space. Project Walk – Boston ... and adding technology to their continuum of care. They now have ... repetitions which has been shown to improve gait with patients. The ...
(Date:1/24/2017)... Jan. 24, 2017  Applied BioMath ( ... modeling to drug research and development, today ... on Biobetters and Next-Generation Biologics: Innovative Strategies ... Wilkins , PhD, Senior Scientist at Applied ... exploration of mechanistic determinants of antibody drug-conjugate ...
(Date:1/24/2017)... , Jan. 24, 2017 Demonstrating its ongoing ... in Lehighton, Pennsylvania has now ... LLC ( www.prairiedogtech.com ). THE OBSERVER is a system ... endoscopes. The system ensures 100% compliance with safety best ... the challenge of preventing the growth and spread of ...
(Date:1/24/2017)... Ohio (PRWEB) , ... January ... ... announced the release of Version 5.0 of its award-winning CERF ELN ... is a 21CFR11 compliant, collaborative, knowledge asset manager used by laboratories, regulated ...
Breaking Biology Technology: